BusinessBioMarin to Host First Quarter 2016 Financial Results Conference Call and Webcast on Thursday, April 28 at 4:30pm ETBy Nasdaq OMXApr 12, 2016, 12:30 PM UTC
BusinessDBV Technologies Announces Publication of Experimental Data on Targeted Regulatory T Cell Induction during Epicutaneous ImmunotherapyBy Nasdaq OMXApr 11, 2016, 8:35 PM UTC
BusinessRegenerative Medicine Foundation to Highlight Need for New Regulatory Pathway for Cell Therapies at April 12th EventBy Nasdaq OMXApr 11, 2016, 3:36 PM UTC
BusinessCuris Announces Presentation of Preclinical Data from CUDC-907, CA-170 and PD-L1/TIM-3 Antagonist and CA-4948 Programs at AACR Annual MeetingBy Nasdaq OMXApr 11, 2016, 11:00 AM UTC
BusinessFocal Therapeutics Launches BioZorb LP, Expanding Utility of 3D Implant for Breast Cancer PatientsBy Nasdaq OMXApr 7, 2016, 7:41 PM UTC
BusinessAdaptimmune Announces FDA Acceptance of IND Application for Affinity Enhanced T-Cell Therapy Targeting AFP in Liver CancerBy Nasdaq OMXApr 7, 2016, 1:03 PM UTC
BusinessMetabolix to Highlight Mirel PHA Biopolymers in Packaging Applications at SustPack 2016By Nasdaq OMXApr 7, 2016, 1:00 PM UTC
